News & Updates

Show Multimedia Only
COVID-19 survivors at high risk of subsequent IBS

COVID-19 survivors at high risk of subsequent IBS

21 Apr 2023

Individuals who have contracted COVID-19 at increased risk of developing irritable bowel syndrome (IBS) compared with those who have not been infected, as reported in a study.

21 Apr 2023
Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery

Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery

15 Apr 2023

In patients with early rectal cancer (ERC), endoscopic submucosal dissection (ESD) appears safer and is associated with shorter hospital stay than transanal endoscopic microsurgery (TEM), results of a recent study have shown.

15 Apr 2023
IBD patients at higher risk of Alzheimer’s disease

IBD patients at higher risk of Alzheimer’s disease

13 Apr 2023

Inflammatory bowel disease (IBD) shows an independent relationship with the development of Alzheimer’s disease (AD), with such association being stronger in patients with Crohn’s disease (CD) than those with ulcerative colitis (UC), reveals a study.

13 Apr 2023
Ripretinib improves survival in advanced gastrointestinal stromal tumours

Ripretinib improves survival in advanced gastrointestinal stromal tumours

11 Apr 2023 byStephen Padilla

Treatment with ripretinib provides a prolonged clinical and radiological benefit in patients with advanced gastrointestinal stromal tumours (GIST) within the expanded access program (EAP) in the UK, as shown in a study presented at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

11 Apr 2023